The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adult patients.
This research is looking at a new version of a medicine already used to treat schizophrenia. We call this type of study a 'bioequivalence' study. This means we're checking if the new medicine acts in the same way as the original one when it's in your body. It's a key step to make sure the new version is just as safe and effective. We need healthy adult volunteers to take part, and the study doesn't involve treating any illnesses. It's a short-term study to gather important information about how the body handles the medicine.
At a glance
What is this study about?
This study is important because it's helping to check a new version of a medicine that's already used to help people with schizophrenia. When a medicine is first developed, it goes through a lot of testing. Sometimes, a different company might want to make their own version of that medicine, perhaps to make it more widely available or at a lower cost. Before this new version can be used by patients, we need to be absolutely sure it works in exactly the same way as the original.
That's where this study comes in. It's called a 'bioequivalence' study, which simply means 'equal in the body'. We're comparing the new version (the 'test product') with the original one (the 'reference product'). The main goal is to see if the new medicine is absorbed into the bloodstream at the same speed and to the same amount as the original. If they are very similar, then doctors can be confident that the new version will have the same effects as the one they're already familiar with.
It's important to know that this study is not about finding a new treatment for schizophrenia itself. Instead, it's about making sure that a new, similar version of an existing treatment is just as good. This helps make sure patients continue to receive effective care. Because we're just looking at how the body handles the medicine, we need healthy volunteers, not people with schizophrenia, to take part.
Key takeaways
- This study compares a new version of a schizophrenia medicine to the original.
- The goal is to ensure the new version works just as effectively in the body.
- Healthy adult volunteers are needed, aged 18 and over.
- It involves taking the study medicine and having blood samples taken.
- Your safety and comfort are the top priorities throughout the study.
- You can withdraw from the study at any time without needing a reason.
Who may be eligible?
This study is open to anyone over the age of 18. There isn't an upper age limit mentioned, so older adults can also consider taking part. Both men and women are welcome to volunteer.
Since this study is about how a medicine works in healthy people, you must not have any major ongoing health problems. The healthcare team will check your general health carefully to make sure it's safe for you to take part. They'll ask about your medical history and do some tests.
Specific details about other health conditions, medicines you might be taking, or lifestyle choices (like smoking or drinking) that could affect your ability to join will be discussed by the study staff. They want to ensure your safety and that the study results are clear.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you in generally good health?
- Are you able to visit the study clinic for appointments?
- Are you comfortable having regular blood samples taken?
- Are you able to follow specific instructions about medicine and diet?
What does participation involve?
If you decide to take part, you'll be given the new study medicine at certain times. This will likely involve a stay at the study clinic for a short period, probably overnight or for a couple of nights, on different occasions. During these visits, nurses and doctors will regularly take blood samples from you to measure how the medicine is moving through your body. You might also have your blood pressure and heart rate checked frequently.
Before you start, you'll have a screening appointment. This is to make sure you're healthy enough for the study. It will involve a medical check-up, some blood and urine tests, and a review of your health history. After you've taken the medicine, there will be follow-up checks to make sure you're feeling well and haven't had any unexpected effects. The total duration of your involvement, including all visits and follow-ups, will be clearly explained before you agree to take part.
Potential risks and benefits
Locations (1)
- —UnverifiedCzechia
Common questions
What is 'bioequivalence'?
It means we're checking if the new medicine works the same way in your body as an existing one, reaching the bloodstream at the same speed and level.
Will I be given a medicine for schizophrenia?
No, you will be given a version of a medicine used for schizophrenia, but the study is not treating you for that condition. You need to be healthy to participate.
How long will I need to be involved?
The exact duration will depend on the study design, but bioequivalence studies often involve a few short clinic stays and follow-up visits. This will be fully explained before you join.
Do I need to stop taking my usual medicines?
You will need to discuss all medicines, including over-the-counter ones, vitamins, and supplements, with the study team. They will advise if any need to be stopped.
Will I get paid for taking part?
Many healthy volunteer studies offer payment for your time and inconvenience. This will be fully discussed with you by the study team.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.